VCN-01 oncolytic adenovirus development in pediatric retinoblastoma
Orphan Drugs & Rare Diseases Global Congress Europe 2025 · 19 March 2025 · 14:40 · Auditorium 1
VCN-01 oncolytic adenovirus development in pediatric retinoblastoma was a session at Orphan Drugs & Rare Diseases Global Congress Europe 2025 on 19 March 2025 in London, with 1 speaker on record.
Speakers
- Manel Cascalló — Speaker General Director EU Subsidiary & Founder, Theriva Biologics